# 302 - Confronting a metabolic epidemic: how to prevent, diagnose, & manage liver disease

**Channel:** Peter Attia MD
**Upload Date:** 2024-05-20
**URL:** https://www.youtube.com/watch?v=ZiJ2th4rKKA
**Duration:** 157 minutes

## Description

View show notes here: https://bit.ly/3Kr5a4Z
Become a member to receive exclusive content: https://peterattiamd.com/subscribe/
Peter's email newsletter: https://peterattiamd.com/newsletter/

Julia Wattacheril is a physician scientist & director of the Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) program at Columbia University Irving Medical Center. In this episode, Julia delves deep into the complex world of liver health, beginning with a foundational overview of liver physiology. She provides an in-depth look at how alcohol impacts liver function, breaking down the metabolism of ethanol & its detrimental effects. Julia then shifts the focus to understanding liver function tests & optimal enzyme levels, providing a detailed explanation of AST & ALT & elucidating why fluctuations in these levels may or may not be concerning. She provides a primer on the four major stages of liver disease, discussing risk & emphasizing the importance of early diagnosis. Julia highlights the role of liver disease in increasing the risk of cancer & cardiovascular disease & covers in detail the various strategies for diagnosing, treating, & preventing the progression of liver disease. Dr. Wattacheril’s views expressed in this conversation reflect her own, not those of her institution.

We discuss:
0:00:00-Intro
0:01:52-Julia’s training, importance of liver health, & innovations of hepatology
0:08:14-The crucial functionality of the liver & its four most essential functions
0:13:36-Liver injuries: understanding causal factors & the progression to liver diseases & cancer
0:26:03-How the liver metabolizes nutrients & what happens in the presence of excess calories
0:35:39-Methods of diagnosing liver disease
0:43:45-The poisonous nature of ethanol
0:51:19-Varied responses to alcohol, damaging effects of alcohol beyond the liver, & advising patients on their alcohol consumption
1:03:59-Liver enzymes AST & ALT—interpreting levels, lifestyle factors that affect them, & diagnostic approaches
1:20:39-Interpreting liver function tests for fatty liver disease, & diagnosing liver pathologies, particularly in children versus adults
1:26:45-Comprehensive liver health assessments via imaging & various diagnostic tools to prevent overlooking potential liver pathologies
1:35:32-Impact of recreational drugs, statins, & other medications on liver function test results
1:39:49-Shifting nomenclature from NAFLD to MASLD
1:46:40-Pathophysiology of MASLD, the need for proactive screening, & the significance of liver fat percentage
1:53:46-Screening for rare conditions alongside common metabolic diseases associated with fatty liver
1:56:50-Practical strategies for managing MAFLD
2:05:10-Impact of fructose consumption on liver health & the challenges of disentangling its effects from obesity & insulin resistance
2:10:20-The potential of GLP-1 agonists for the treatment of MASLD
2:13:31-4 stages of liver disease
2:18:21-Increased cancer & heart disease risk associated with early-stage MAFLD
2:26:18-Emerging drugs & therapies for addressing fat accumulation & fibrosis related to MAFLD
2:33:33-Takeaways
--------
About:

The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, & all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, & much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan & simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on: 
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify 

Disclaimer: This podcast is for general informational purposes only & does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information & the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, & they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures & the companies I invest in or advise, please visit my website where I keep an up-to-date & active list of such companies. For a full list of our registered & unregistered trademarks, trade names, & service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

Here's a comprehensive analysis of the episode:

1. **Executive Summary**:
This episode features Dr. Julia Wattacheril, a transplant hepatologist, discussing liver disease with a focus on metabolic dysfunction-associated steatotic liver disease (MLED/MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD). The discussion covers the liver's essential functions, disease progression, diagnostic approaches, and treatment options. A key emphasis is placed on the liver's role in metabolism and the growing epidemic of metabolic-associated liver disease, which affects 25-35% of the population.

2. **Key Medical/Scientific Points**:
- Liver has over 300 functions, with no effective external support system available [00:03:01]
- MLED/MASLD affects 25-35% of the US population [01:50:52]
- Disease progression typically takes 5-7 years between stages [01:22:25]
- Coffee consumption (up to 3 cups daily) shows beneficial effects for liver health [02:02:45]
- Early-stage liver disease is more likely to cause cardiovascular problems than liver failure [02:19:19]

3. **Health Optimization Tips**:

Universal recommendations:
- Regular exercise combining aerobic and resistance training [02:01:11]
- Limiting processed foods [02:09:30]
- Coffee consumption (up to 3 cups daily) [02:02:45]

Context-specific recommendations:
- Weight loss for those with metabolic dysfunction [01:56:56]
- Lifestyle modifications before considering medication [02:13:16]

4. **Supplements & Medications**:

Medications discussed:
- GLP-1 agonists (semaglutide, tirzepatide) [02:10:48]
- Resmetirom (thyroid hormone receptor agonist) [02:27:08]
- Vitamin E (with cautions about long-term use) [02:29:03]

5. **Biomarkers & Testing**:

Lab tests recommended:
- ALT/AST (transaminases) [01:04:51]
- Fibroscan/elastography [01:31:27]
- MRI-PDFF for fat quantification [01:31:27]

6. **Notable Quotes**:
"When I see a patient, I am trying to figure out what is the leading risk for their not just mortality but quality of life implication" [02:20:01]

7. **Follow-up Questions**:
- What is the optimal timing for screening in early-stage MLED?
- How do different ethnic populations respond to various treatments?
- What is the role of mitochondrial uncoupling agents in treatment?

Would you like me to expand on any of these sections or provide additional details from other categories?
